GS-441524
53 Inquiries
1191237-69-0
Pharmaceutical Grade
99%
Any China Port
1kg/as customer's requirment
Yes
2020-05-22
API,Intermediate
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceGS-441524 is a nucleoside analogue that terminates the RNA chain of viral RNA-dependent RNA polymerase. GS-441524 was developed by Gilead Sciences, Inc as part of their research into human RNA virus disease such as Ebola. GS-441524 is a small molecule that exhibits potent antiviral activity against a number of RNA viruses, including the zoonotic severe acute respiratory syndrome (SARS) coronavirus ( Cho et al., 2012).
GS-441524 is a C-nucleoside analog that is (2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile substituted by a 4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl group at position 2. It is the active metabolite of remdesivir and exhibits a broad range of inhibitory activity against various RNA viruses including HCV, parainfluenza and SARS-CoV. It has a role as a drug metabolite, an antiviral agent and an anticoronaviral agent. It is a pyrrolotriazine, a nitrile, a C-nucleoside and an aromatic amine.|GS-441524 is an adenosine nucleotide analog antiviral, similar to [remdesivir]. This molecule was patented in 2009. In vitro studies of GS-441524 have determined it has a higher EC50 than remdesivir against a number of viruses, meaning GS-441524 is less potent. GS-441524 continues to be studied in the treatment of Feline Infectious Peritonitis Virus, a coronavirus that only infects cats.Basic Info-
Product Name:
GS-441524
Other Name:(2R,3R,4S,5R)-2-(4-Aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furancarbonitrile;GS-441524;GS441524;(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile;GS-441524 solution;EVO984;EVO 984;EVO-984;GS 441524
CAS No.:1191237-69-0
Molecular Formula:C12H13N5O4
InChIKeys:BRDWIEOJOWJCLU-LTGWCKQJSA-N
Molecular Weight:291.26
Exact Mass:291.096754
UNII:1BQK176DT6
Characteristics-
PSA:
150
XLogP3:-1.27552
Density:1.84±0.1 g/cm3(Predicted)
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
API,Intermediate
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
30 days
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
About Echemi Pharmaceutical
Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.
Advantage for Pharmaceutical
• Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.
• We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.
• We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.
Product Category
We care for human and animal health and we are committed to creating a better social environment.
• Human API
• Intermediate
• Veterinary API
• Agrochemical
• Fine Chemical
• Custom Synthesis
-
-
Inquiry History53 Inquiries
Country Product Purchase Quantity Date Posted 
Turkey
GS441524 powder CAS 1191237-69-0 Remdesivir GS-5734 Alprostadil pge
1 PCS Jan 6, 2026 
Bulgaria
Lowest price in the whole network 1191237-69-0 GS-441524
100 BOU Nov 8, 2023 
China
GS 441524
1 KG Dec 5, 2023 
Japan
GS-441524
100 MT Oct 2, 2026 
Italy
Gs-441524
20 MG Sep 28, 2026 
Mexico
Fip Cat Gs-441524 Fipv
1 KG Jul 3, 2026 
Malaysia
Gs-441524
10 MG Jun 15, 2026
China
GS-441524
1680 MG May 2, 2026 
Poland
GS-441524
100 G Feb 25, 2026
Poland
GS-441524
1 KG Feb 25, 2026
Turkey
gs-441524
100 G Feb 20, 2026 
Bangladesh
Gs-441524 fipv
1 MT Jan 26, 2026 
Czech
GS-441524
1000 PCS Nov 5, 2025
Italy
GS-441524
100 G Oct 28, 2025 
Pakistan
GS441524
1 KG Aug 5, 2025
Turkey
GS-441524
100.00 G Jun 30, 2025
Bulgaria
Gs-441524
100 MT Dec 6, 2024
Pakistan
GS441
10 MT Nov 28, 2024
Pakistan
GS441524,
1 KG Sep 4, 2024
Bulgaria
Fast Delivery Fip for Cat GS441 6ml 8ml Liquid Fip
100 BOU Nov 8, 2023 Post an enquiry for this product
More from this Seller
-
-
![Vortioxetine hydrobromide]( "Vortioxetine hydrobromide")
-
Vortioxetine hydrobromide
Pharmaceutical Grade / 99%
-
-
-
![2-aminopropanediamide]( "2-aminopropanediamide")
-
2-aminopropanediamide
Pharmaceutical Grade / 99%
-
-
-
![Mirabegron]( "Mirabegron")
-
Mirabegron
Pharmaceutical Grade / 99%
-
-
-
![Cyromazine]( "Cyromazine")
-
Cyromazine
Pharmaceutical Grade / 99%
-
-
-
![Hydroxy Navaldiamine]( "Hydroxy Navaldiamine")
-
Hydroxy Navaldiamine
Pharmaceutical Grade / 98%
-
-
-
![Vildagliptin as customer's requirment]( "Vildagliptin as customer's requirment")
-
Vildagliptin as customer's requirment
Pharmaceutical Grade / 99.5%
-
